维普中文期刊产品整合服务
20篇 您的检索式:作者名="Mahteme"
    题名 作者 年代 出处 被引量
1Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in China's Mainland显示文摘AIM:To investigate the current status of peritoneal carcinomatosis(PC) management,as well as the usage of cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC) in China's Mainland.METHODS:A potentially curative therapeutic strategy for selecting patients with PC,known as 'Techniques',consists of CRS in combination with HIPEC.A systemic search of published works and clinical trials was performed.Additional papers were retrieved by crosschecking references and obtaining information from Chinese oncologists and relevant conferences.One hundred and one papers and one registered clinical trial on HIPEC were included.RESULTS:A literature review identified 86 hospitals in 25 out of all 31 areas of China's Mainland that perform HIPEC.The earliest report included in our survey was published in 1993.Different approaches to HIPEC have been utilized,i.e.palliative,prophylactic,and possiblycurative treatment.Only one center has consistently performed HIPEC according to the 'Sugarbaker Protocol',which involves evaluating the extent of PC with peritoneal cancer index and the results of CRS with the completeness of cytoreduction.Positive preliminary results were reported:7 of 21 patients with PC survived,free of tumors,during an 8-43-mo follow-up period.Hyperthermic strategies that include HIPEC have been practiced for a long time in China's Mainland,whereas the 'Sugarbaker Protocol/Techniques' has been only rarely implemented in China.The Peritoneal Surface Oncology Group International hosts a biannual workshop with the intent to train more specialists in this field and provide support for the construction of quality treatment centers,especially in developing countries like China,whose population is huge and has a dramatically increased incidence of cancer.CONCLUSION:To popularize Sugarbaker Protocol/Techniques in China's Mainland in PC management arising from gastric cancer or colorectal cancer will be the responsibility of the upcoming Chinese Peritoneal Surface Oncology Group.Tao Suo Haile Mahteme Xin-Yu Qin 2011World Journal of Gastroenterology2011,17,8:18
2Diabetes mellitus is associated with increased mortality during tuberculosis treatment:a prospective cohort study among tuberculosis patients in SouthEastern Amahra Region,Ethiopia显示文摘Background:There is growing evidence suggesting that diabetes mellitus(DM)affects disease presentation and treatment outcome in tuberculosis(TB)patients.This study aimed at investigating the role of DM on clinical presentations and treatment outcomes among newly diagnosed TB patients.Methods:A prospective cohort study was conducted in South-Eastern Amhara Region,Ethiopia from September 2013 till March 2015.Study subjects were consecutively recruited from 44 randomly selected health facilities in the study area.Participants were categorized into two patient groups,namely,patients with TB and DM(TBDM)and TB patients without DM(TBNDM).Findings on clinical presentations and treatment outcomes were compared between the two patient groups.Cox proportional hazard regression analysis was applied to identify factors associated with death.Results:Out of 1314 TB patients enrolled in the study,109(8.3%)had coexisting DM.TBDM comorbidity[adjusted hazard ratio(AHR)3.96;95%confidence interval(C.I.)(1.76–8.89)],and TB coinfection with human immunodeficiency virus(HIV)[AHR 2.59;95%C.I.(1.21–5.59)]were associated with increased death.TBDM and TBNDM patients did not show significant difference in clinical symptoms at baseline and during anti-TB treatment period.However,at the 2nd month of treatment,TBDM patients were more symptomatic compared to patients in the TBNDM group.Conclusions:The study showed that DM is associated with increased death during TB treatment.DM has no association with clinical presentation of TB except at the end of the intensive phase treatment.Routine screening of TB patients for DM is recommended for early diagnosis and treatment of patients with TBDM comorbidity.Mahteme Haile Workneh Gunnar Aksel Bjune Solomon Abebe Yimer 2016Infectious Diseases of Poverty2016,5,1:2
3Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study显示文摘P.H. Cashin W. Graf P. Nygren H. Mahteme 2012European Journal of Surgical Oncology2012,,6:2
4Comparison of Prognostic Scores for Patients with Colorectal Cancer Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy显示文摘Peter H. Cashin Wilhelm Graf Peter Nygren Haile Mahteme 2013Annals of Surgical Oncology2013,,:1
5Hetergeneous activity of cytotoxic drugs in patients samples of peritoneal carcinomatosis显示文摘Mahteme H von Heideman A Grundmark B 2008European Journal of Surgical Oncology2008,34,5:1
6Cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy treatment of colorectal peritoneal metastases: Cohort analysis of high volume disease and cure rate显示文摘Peter H Cashin Faoz Dranichnikov Haile Mahteme 2014J. Surg. Oncol2014,,:1
7Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial显示文摘P.H. Cashin H. Mahteme N. Sp?ng I. Syk J.E. Fr?din M. Torkzad B. Glimelius W. Graf 2015European Journal of Cancer2015,,:1
8Good Colorectal Cancer Surgery显示文摘Mahteme H Pahlman L 2005Tech Coloproctol2005,9,:1
9Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy显示文摘E. Arakelian L. Gunningberg J. Larsson K. Norlén H. Mahteme 2011European Journal of Surgical Oncology2011,,10:1
10Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: Aspects of the learning curve显示文摘H. Andréasson T. Lorant L. P?hlman W. Graf H. Mahteme 2014European Journal of Surgical Oncology2014,,:1
11Pharmacodynamic aspects of intraperitoneal cytotoxic therapy显示文摘Ceelen WP Pahlman L Mahteme H 2007Cancer Treat Res2007,134,:1
12Septic Complications and Prognosis After Surgery for Rectal Cancer显示文摘Ulf Kressner M.D. Ph.D. Wilhelm Graf M.D. Ph.D. Haile Mahteme M.D. Ph.D. Lars P?hlman M.D. Ph.D. Bengt Glimelius M.D. Ph.D 2002Diseases of the Colon & Rectum2002,,3:1
13A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin显示文摘Van der Speeten K Stuart OA Mahteme H 2013Cancer Chemother Pharmacol2013,,63:1
14Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis显示文摘B. L. van Leeuwen MD PhD W. Graf MD PhD L. Pahlman MD PhD H. Mahteme MD PhD 2008Annals of Surgical Oncology2008,,3:1
15Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer显示文摘Bo Hultman Jonas Lundkvist Bengt Glimelius Peter Nygren Haile Mahteme 2012Acta Oncologica2012,,1:1
16Cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy treatment of colorectal peritoneal metastases: Cohort analysis of high volume disease and cure rate显示文摘Peter H Cashin Faoz Dranichnikov Haile Mahteme 2014Oncol2014,,2:1
17Treatment of peritoneal surface malignancy by peritonectomy and intraperitoneal chemotherapy:a novel therapy with curative potential 显示文摘Mahteme H Pahlman L 2005Minerva Chir2005,60,3:1
18Polycyclic Aromatic Hydrocarbons in Electrocautery Smoke during Peritonectomy Procedures 显示文摘Naslund Andrrasson S Mahteme H Sahlberg B 2012J Environ Public Health2012,2012,92:1
19Pharmacology of perioperative 5-fluorouracil显示文摘Van der Speeten K Stuart OA Mahteme H 2010J Surg Oncol2010,102,7:1
20Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin显示文摘Mahteme H Sugarbaker PH 2004Br J Surg2004,91,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费